-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q2 2017 to Q3 2018.
- Dianthus Therapeutics, Inc. /DE/ Income Tax Expense (Benefit) for the quarter ending September 30, 2018 was $0.000.
- Dianthus Therapeutics, Inc. /DE/ annual Income Tax Expense (Benefit) for 2023 was $0.000.
- Dianthus Therapeutics, Inc. /DE/ annual Income Tax Expense (Benefit) for 2022 was $0.000.
- Dianthus Therapeutics, Inc. /DE/ annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)